DOCS — Dr Martens Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMid CapSuper Stock

Annual income statement for Dr Martens, fiscal year end - March 29th, GBP millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 30th	2026 March 29th
Period Length:	12 M	12 M	12 M	52 W	52 W
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	908	1,000	877	788	765
Cost of Revenue
Gross Profit	579	618	575	512	506
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	679	824	755	751	708
Operating Profit	229	176	122	37	57
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	214	159	93	8.8	32.7
Provision for Income Taxes
Net Income After Taxes	181	129	69.2	4.5	23.8
Net Income Before Extraordinary Items
Net Income	181	129	69.2	4.5	23.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	181	129	69.2	4.5	23.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.181	0.132	0.07	0.039	0.054
Dividends per Share